Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis
 and differential diagnosis are not yet available. Exhaled breath testing may yield a
 "breath-print" that can be used to distinguish healthy and diseased states.
Inclusion Criteria:

 -  Patients with Parkinsonism

 Exclusion Criteria:

 -  Severe dementia